Human papillomavirus (HPV) is a widespread sexually transmitted virus that can cause various health problems, ranging from genital warts to cancer. This article provides a detailed overview of HPV, its prevalence, risk factors, associated health problems, diagnostics, treatment, and prevention, including the importance of vaccination and its safety aspects.

What is human papillomavirus?

Virus characteristics

Human papillomavirus (HPV) is a small, non-enveloped DNA virus belonging to the Papillomaviridae family. It contains double-stranded DNA and consists of a capsid that protects its genetic material. HPV is a highly adaptive virus capable of infecting both skin and mucous membranes, thereby causing various clinical manifestations. HPV viruses are very common and are classified into more than 200 different types, each of which can cause different symptoms and complications. Some of them are associated with benign lesions, such as warts that can also appear on the skin, while others are known as high-risk types that are associated with oncogenic changes and cancer development.

HPV types and prevalence

HPV viruses are classified into two main categories: low-risk and high-risk types. Low-risk HPV types, such as HPV 6 and 11, usually cause benign lesions, such as genital warts and skin warts. High-risk HPV types, such as HPV 16 and 18, are associated with the development of cervical, anal, oropharyngeal, and other cancers. According to the World Health Organization (WHO), HPV is one of the most common sexually transmitted viruses, and the majority of sexually active individuals are at risk of infection during their lifetime. Research indicates that HPV infections are very common among young people; however, many of these infections are short-lived, as the immune system is able to clear them without the need for treatment.

Transmission routes and risk factors

How does the virus spread?

HPV is primarily spread through sexual contact, including vaginal, anal, and oral sex. Virus transmission can also occur through skin contact with infected tissues, even if there are no visible symptoms such as warts. Condom use can reduce the risk of HPV transmission, but it does not completely eliminate the possibility of infection, as the virus can also be present on the skin around the genitals that is not covered by a condom. HPV can also be transmitted from mother to child during childbirth, although this occurs less frequently and can cause respiratory papillomatosis in the child.

Risk factors

The risk of developing an HPV infection depends on several factors. Common risk factors include early onset of sexual activity, a large number of sexual partners, and frequent change of sexual partners. Weakening of the immune system, which can be caused by HIV infection or immunosuppressive therapy, also increases the risk of HPV infection and its progression to oncogenic changes. Tobacco smoking is another factor associated with an increased risk of cervical cancer in the presence of HPV infection. Furthermore, failure to follow vaccination recommendations that could help prevent infections with high-risk HPV types increases the risk of developing HPV-related cancer.

Health problems caused by HPV

Genital warts

Genital warts are a common manifestation of HPV infection, usually caused by low-risk HPV types such as HPV 6 and 11. They present as small, skin-colored or pink warts on the genitals and anal area. Although these warts are usually not painful, they can cause discomfort and cosmetic concerns. Genital warts may appear several weeks or months after infection, and their treatment involves topical or surgical intervention to reduce symptoms and prevent their spread.

Cancer risks

HPV infections with high-risk types, particularly HPV 16 and 18, are the primary cause of cervical cancer development. Cervical cancer is one of the most common types of cancer in women, and nearly all cases of cervical cancer are caused by persistent HPV infection. In addition to cervical cancer, high-risk HPV types are also associated with the development of other anogenital cancers, such as anal, vulvar, vaginal, and penile cancers. Furthermore, oropharyngeal cancer, which develops in the throat, base of the tongue, and tonsil area, is increasingly linked to HPV infections, especially in Western countries where oral sex is more common. The immune system's inability to clear high-risk HPV infections is the main factor leading to cellular dysplasia and, ultimately, cancer development.

Diagnostics and treatment

How is HPV diagnosed?

HPV infection diagnostics is primarily based on clinical examination and laboratory tests. Additional tools, such as the Pap test (Papanicolaou test) and HPV DNA test, are used to detect cervical cell changes and identify high-risk HPV types. The Pap test is a screening method performed to detect early cellular changes in the cervical epithelium. The HPV DNA test is a more specific test that identifies cancer-causing HPV types and is often used together with the Pap test for high-risk patients. A biopsy may also be used to confirm suspicious lesions.

Treatment options

HPV infections themselves often do not present with symptoms and in most cases are cleared naturally by the immune system. However, if the infection causes symptoms or persists, treatment may be necessary. Treatment of genital warts may include topical treatment with creams or solutions, cryotherapy, or surgical removal. The choice of treatment depends on the patient's individual situation and should be made after consultation with a doctor. Treatment of cervical cancer precursors involves methods such as loop electrosurgical excision procedure (LEEP) or conization to remove affected tissue. In the case of oncological lesions, treatment options may include surgery, chemotherapy, and radiation therapy, depending on the type and stage of cancer. It is important to follow regular screening recommendations and follow the doctor's instructions to ensure early detection and treatment.

Prevention and vaccination

Preventive measures

Prevention strategies against HPV infection include several measures to reduce the risk of infection. Condom use during sexual intercourse reduces the risk of HPV transmission, although it does not completely eliminate the possibility of becoming infected with the virus. Regular screening, such as Pap tests for women, helps detect early cervical cell changes that can prevent cancer development. Improving sexual education, including awareness about HPV and its modes of transmission, is essential to promote safe sexual practices and reduce the practice of having multiple sexual partners, which is a significant risk factor.

Importance of vaccination

Vaccination against HPV is an effective strategy to prevent infections with high-risk HPV types and reduce the risk of HPV-related cancer. Currently available vaccines, such as Gardasil 9, provide protection against multiple HPV types, including those most commonly associated with cancer and genital warts. The WHO and health authorities in many countries recommend HPV vaccination as part of national immunization programs, primarily targeting adolescents aged 9 to 14 years, before the onset of sexual activity. Vaccination is safe and effective, and its implementation can significantly reduce the prevalence of HPV and the number of associated health problems.

Vaccination side effects and contraindications

HPV vaccines have been extensively studied and are considered safe. However, as with any vaccine, side effects may occur. The most common side effects are pain at the injection site, headaches, and fatigue, which are usually mild and transient. In rare cases, allergic reactions may occur, so vaccination should only be administered after consulting a doctor, especially if allergies or other health problems exist. HPV vaccines are effective only against certain HPV types and do not replace regular screening, so it is important to continue regular medical check-ups.

Latest research and developments

Scientific research continues to uncover new aspects of HPV and its association with various diseases. In recent years, attention has been paid not only to HPV-related cancers but also to its impact on fertility and reproductive health. Some studies suggest that persistent HPV infection may affect female fertility and increase the risk of miscarriage, but these issues are still being researched. Additionally, new vaccines and therapeutic options are being developed that could offer protection against even more HPV types and improve the effectiveness of existing vaccines.

Public health significance

From a public health perspective, the implementation of HPV vaccination programs is a crucial step in the fight against HPV-related diseases. Effective implementation of vaccination campaigns can significantly reduce the incidence of cervical cancer, which is one of the leading causes of female mortality in many countries. Improving accessibility and education about the importance of HPV vaccination are essential elements to achieve high vaccination coverage and reduce the global burden of HPV-related diseases.

Conclusions

Human papillomavirus is a widespread virus that can cause serious health problems if not properly controlled. Understanding the modes of virus transmission, risk factors, and associated diseases is essential to promote preventive measures and reduce the risk of HPV-related cancer. Vaccination is an effective method to prevent infections with high-risk HPV types, and its widespread implementation can help reduce the burden of cancer in society. Regular screening and adherence to safe sexual practices are additional measures that can promote early detection and treatment, thereby preserving patient health and safety. Public health initiatives aimed at education and improving vaccination accessibility are essential to combat HPV-related diseases and their consequences on a global scale.